Abstract
AbstractDendritic cells (DC) and Natural killer (NK) cells engage in reciprocal interactions to trigger an efficient innate immune response while governing the adaptive immune response. Here we used anex vivoautologous human primary immune cell co-culture of DCs and NK cells to investigate the impact of DC-NK cell crosstalk on activation of CD4+and CD8+naïve T cell responses to influenza A viral (IAV) infection. Using multiparameter flow cytometry, we observed that culturing T cells with DC and NK cells led to enhanced expression of CD69 and CD25 activation markers and increased proliferative ability of both CD4+and CD8+T cell subsets. Exposure of DCs to the pandemic A/California/07/2009 (H1N1) strain in NK cell co-culture led to a reduced frequency of CD4+CD69+, CD8+CD69+, CD4+CD25+, CD8+CD25+T cell subsets and a reduced expansion of CD4+T cells. The IAV-mediated curtailment of T cell activation was dependent on the ability of A/California/07/2009 (H1N1) to replicate as inactivation of the virus rescued expression of CD69, CD25 on both CD4+and CD8+T cell subsets and triggered expansion of CD4+T cells. Further, we discovered exposure of DCs to the A/Victoria/361/2011 (H3N2) IAV strain also significantly impaired expression of CD69 on CD4+and CD8+T cells and CD25 on CD8+T cells. In contrast with the A/California/07/2009 (H1N1 strain), inactivation of A/Victoria/361/2011 (H3N2) failed to fully restore T cell expression of CD69 and CD25 and proliferation. Collectively, these data demonstrate that IAV partially usurps the ability of DC-NK cell crosstalk to activate naïve CD4+and CD8+T cells in a strain-dependent manner. These data may inform the immunological signals required to trigger a potent cellular immune response to IAV, which may elicit broader and more durable protection than current inactivated vaccine platforms.
Publisher
Cold Spring Harbor Laboratory
Reference54 articles.
1. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study;The Lancet Respiratory Medicine,2017
2. Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
3. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates
4. Davis CW , Jackson KJL , McCausland MM , Darce J , Chang C , Linderman SL , Chennareddy C , Gerkin R , Brown SJ , Wrammert J , Mehta AK , Cheung WC , Boyd SD , Waller EK , Ahmed R . Influenza vaccine–induced human bone marrow plasma cells decline within a year after vaccination. Science. 2020;370(6513):237–41.